Patrick T. Horn

1.8k total citations
39 papers, 1.2k citations indexed

About

Patrick T. Horn is a scholar working on Genetics, Molecular Biology and Rheumatology. According to data from OpenAlex, Patrick T. Horn has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Molecular Biology and 7 papers in Rheumatology. Recurrent topics in Patrick T. Horn's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Urticaria and Related Conditions (6 papers) and Pediatric Hepatobiliary Diseases and Treatments (5 papers). Patrick T. Horn is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Urticaria and Related Conditions (6 papers) and Pediatric Hepatobiliary Diseases and Treatments (5 papers). Patrick T. Horn collaborates with scholars based in United States, Italy and France. Patrick T. Horn's co-authors include William E. Pullman, Marilyn Campion, Robyn J. Levy, William R. Lumry, H. Henry Li, Donald McNeil, Albert L. Sheffer, Joyce A. Sutcliffe, Joseph S. Solomkin and Anthony J. Castaldo and has published in prestigious journals such as New England Journal of Medicine, Journal of Allergy and Clinical Immunology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Patrick T. Horn

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick T. Horn United States 14 659 301 241 225 221 39 1.2k
David C. Henke United States 14 94 0.1× 85 0.3× 46 0.2× 11 0.0× 228 1.0× 24 975
G. A. R. Young Australia 15 92 0.1× 19 0.1× 42 0.2× 23 0.1× 216 1.0× 48 985
Demet Nalbant United States 18 124 0.2× 65 0.2× 6 0.0× 29 0.1× 309 1.4× 38 897
Junichi Nakamura Japan 19 41 0.1× 87 0.3× 79 0.3× 11 0.0× 209 0.9× 106 1.5k
William H. Vaughn United States 12 75 0.1× 435 1.4× 67 0.3× 4 0.0× 179 0.8× 16 856
Şükrü Palanduz Türkiye 18 47 0.1× 47 0.2× 54 0.2× 11 0.0× 400 1.8× 90 1.0k
Noriaki Iino Japan 19 35 0.1× 63 0.2× 124 0.5× 7 0.0× 524 2.4× 66 1.4k
Ian R. Witherden United Kingdom 12 64 0.1× 26 0.1× 81 0.3× 12 0.1× 400 1.8× 13 1.2k
Anna Stelmaszczyk‐Emmel Poland 16 30 0.0× 36 0.1× 133 0.6× 10 0.0× 239 1.1× 84 1.2k
M. Sinaasappel Netherlands 23 106 0.2× 32 0.1× 56 0.2× 5 0.0× 519 2.3× 70 2.1k

Countries citing papers authored by Patrick T. Horn

Since Specialization
Citations

This map shows the geographic impact of Patrick T. Horn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick T. Horn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick T. Horn more than expected).

Fields of papers citing papers by Patrick T. Horn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick T. Horn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick T. Horn. The network helps show where Patrick T. Horn may publish in the future.

Co-authorship network of co-authors of Patrick T. Horn

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick T. Horn. A scholar is included among the top collaborators of Patrick T. Horn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick T. Horn. Patrick T. Horn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gwaltney, Chad, et al.. (2022). Validation of the PRUCISION Instruments in Pediatric Patients with Progressive Familial Intrahepatic Cholestasis. Advances in Therapy. 39(11). 5105–5125. 6 indexed citations
3.
Verkade, Henkjan J., Folkert Kuipers, Quanhong Ni, et al.. (2021). Pretreatment serum bile acid parameters and predictability of response to odevixibat, an ileal bile acid transport inhibitor, in children with progressive familial intrahepatic cholestasis. Journal of Hepatology. 75. 1 indexed citations
4.
5.
Solomkin, Joseph S., David C. Evans, Algirdas Šlepavičius, et al.. (2016). Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial. JAMA Surgery. 152(3). 224–224. 189 indexed citations
6.
Sheffer, Albert L., Marilyn Campion, Robyn J. Levy, et al.. (2011). Ecallantide (DX-88) for acute hereditary angioedema attacks: Integrated analysis of 2 double-blind, phase 3 studies. Journal of Allergy and Clinical Immunology. 128(1). 153–159.e4. 49 indexed citations
7.
Cicardi, Marco, Robyn J. Levy, Donald McNeil, et al.. (2010). Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema. New England Journal of Medicine. 363(6). 523–531. 234 indexed citations
8.
Levy, Robyn J., William R. Lumry, Donald McNeil, et al.. (2010). EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. Annals of Allergy Asthma & Immunology. 104(6). 523–529. 116 indexed citations
9.
Stolz, Leslie E. & Patrick T. Horn. (2010). Ecallantide: A plasma kallikrein inhibitor for the treatment ofacute attacks of hereditary angioedema. Drugs of today. 46(8). 547–547. 12 indexed citations
10.
Horn, Patrick T., et al.. (1993). Effectiveness of a targeted screening program in identifying infants with positive urine toxicology screening results in a regular neonatal nursery. The Journal of Pediatrics. 123(1). 137–139. 12 indexed citations
11.
Kohli, Jai D., Patrick T. Horn, Dana Glock, William K. Brewster, & David E. Nichols. (1993). Dihydrexidine: a new potent peripheral dopamine D1 receptor agonist. European Journal of Pharmacology. 235(1). 31–35. 8 indexed citations
12.
Horn, Patrick T.. (1992). Persistent hypertension after prenatal cocaine exposure. The Journal of Pediatrics. 121(2). 288–291. 27 indexed citations
13.
Horn, Patrick T. & Jai D. Kohli. (1991). Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature. European Journal of Pharmacology. 197(2-3). 125–130. 8 indexed citations
14.
Horn, Patrick T. & Michael Murphy. (1991). Dopamine receptor agonists in cardiovascular medicine. Trends in Cardiovascular Medicine. 1(3). 103–107. 4 indexed citations
15.
Fink, Donald W., Patrick T. Horn, & Bernard L. Mirkin. (1990). Influence of host age and tumor load on the growth and catecholamine content of C-1300 murine neuroblastoma in situ. Cancer Letters. 50(1). 11–18. 1 indexed citations
16.
Horn, Patrick T. & Michael Murphy. (1990). New Dopamine Receptor Agonists in Heart Failure and Hypertension. Drugs. 40(4). 487–492. 6 indexed citations
17.
Horn, Patrick T. & Bernard L. Mirkin. (1990). Modulation of murine neuroblastoma tumor growth by the adrenergic nervous system: Differential response of clonal cell lines to chemical sympathectomy. Life Sciences. 47(24). 2251–2259. 3 indexed citations
18.
Mercuro, Giuseppe, et al.. (1990). Inhibitory effects of catecholamines in the paravertebral sympathetic ganglia of the anesthetized dog. European Journal of Pharmacology. 185(1). 61–68. 2 indexed citations
19.
Horn, Patrick T. & Michael Murphy. (1990). Therapeutic Applications of Drugs Acting on Peripheral Dopamine Receptors. The Journal of Clinical Pharmacology. 30(8). 674–679. 9 indexed citations
20.
Horn, Patrick T. & Bernard L. Mirkin. (1989). Lack of effect of the opioid antagonist, naltrexone, on the growth of C-1300, NIE-115 and NS206 murine neuroblastoma tumor cell lines. Life Sciences. 45(26). 2539–2545. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David C. Henke Breakdown of academic impact, for papers by G. A. R. Young Breakdown of academic impact, for papers by Demet Nalbant Breakdown of academic impact, for papers by Junichi Nakamura Breakdown of academic impact, for papers by William H. Vaughn Breakdown of academic impact, for papers by Şükrü Palanduz Breakdown of academic impact, for papers by Noriaki Iino Breakdown of academic impact, for papers by Ian R. Witherden Breakdown of academic impact, for papers by Anna Stelmaszczyk‐Emmel Breakdown of academic impact, for papers by M. Sinaasappel
Rankless by CCL
2026